Unique ID issued by UMIN | UMIN000025975 |
---|---|
Receipt number | R000028176 |
Scientific Title | Exploratory study of optimal conditions of non-invasive brain stimulation for intractable pain |
Date of disclosure of the study information | 2017/03/01 |
Last modified on | 2020/02/05 12:05:52 |
Exploratory study of optimal conditions of non-invasive brain stimulation for intractable pain
Exploratory study of optimal conditions of non-invasive brain stimulation for intractable pain
Exploratory study of optimal conditions of non-invasive brain stimulation for intractable pain
Exploratory study of optimal conditions of non-invasive brain stimulation for intractable pain
Japan |
intractable pain
Neurology | Anesthesiology | Neurosurgery |
Others
NO
To explore optimal conditions of non-invasive brain stimualtion for treating intractable pain, and to investigate safety and feasibility of the long-term application
Safety,Efficacy
Exploratory
Pain reduction in VAS
Pain reduction in NRS
Frequency and duration of shooting pain, if a subject has a shooting pain
Pain reduction in SF-MPQ 2 (Short form of McGill pain questionnaire 2)
PGIC (Patient global impression of change)
Improvement in PDAS (Pain Disability Assessment Scale)
Improvement in EQ-5D
Improvement in PCS (Pain Catastrophizing Scale)
Improvement in HADS (Hospital Anxiety and Depression Scale)
Change in BDI-II
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
6
Treatment
Device,equipment |
Active rTMS, condition 1
single session
Active rTMS, condition 2
single session
Active rTMS, condition 3
single session
Sham rTMS
single session
Active tDCS
single session
Sham tDCS
single session
20 | years-old | <= |
Not applicable |
Male and Female
1)Patients with intractable pain for 6 months or longer
2)Patients with 30mm or more in VAS at baseline
3)Patients with insufficient pain relief, despite receiving drugs for pain, or a history of using drugs for pain
4)Patients with an informed consent given
1)Patients with dementia (MMSE=<24)
2)Patients with severe aphasia or higher brain dysfunction
3)Patients with a major psychiatric disease
4)Patients with a desire for suicide
5)Patients with a history of epileptic attacks
6)Patients with an implantable cardiac stimulator
7)Patients with an implantable deep brain stimulation devices
8)Patients with an implanted metal in their heads, except for titanium products
9)Pregnant patients
10)Patients who cannot write questionaires
11)Patients without ability of agreements
12)Patients receiving other clinical trials or studies within 6 months before agreements
13)Patients who are considered unsuitable for this clinical trial by a principal or sub investigator
14)Patients with a scalp lesion on the stimulation site (tDCS)
50
1st name | |
Middle name | |
Last name | Youichi Saitoh |
Osaka University
Department of Neuromodulation and Neurosurgery
2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
+81-6-6210-8435
saitoh@nsurg.med.osaka-u.ac.jp
1st name | |
Middle name | |
Last name | Koichi Hosomi |
Osaka University
Department of Neuromodulation and Neurosurgery
2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
+81-6-6210-8435
k-hosomi@nsurg.med.osaka-u.ac.jp
Osaka University Hospital
Osaka University, Japan Agency for Medical Research and Development
Other
NO
大阪大学医学部附属病院
2017 | Year | 03 | Month | 01 | Day |
Unpublished
Completed
2017 | Year | 02 | Month | 02 | Day |
2017 | Year | 02 | Month | 15 | Day |
2017 | Year | 03 | Month | 01 | Day |
2019 | Year | 03 | Month | 29 | Day |
2017 | Year | 02 | Month | 02 | Day |
2020 | Year | 02 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028176